| Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
|---|
| 06/08/2005 | CN1205202C N-carbanilides used as pesticides |
| 06/08/2005 | CN1205188C 4,5-dihydro-1h-pyrazole derivatives having CB1-antagonistic activity |
| 06/08/2005 | CN1205180C 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 06/08/2005 | CN1205179C (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
| 06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/07/2005 | US6903106 Nitrogen compounds having improved solubility, bioavailability and stability, used as sedatives, anxiolytics, anticonvulsant, and/ or muscle relaxants for prophylaxis of sleep disorders |
| 06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/02/2005 | WO2005049601A1 Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1) |
| 06/02/2005 | WO2005049579A2 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets |
| 06/02/2005 | WO2005049578A1 Substituted pyrazoles as ppar agonists |
| 06/02/2005 | WO2005048953A2 Amide derivatives as kinase modulators |
| 06/02/2005 | WO2005048948A2 Urea derivatives as kinase modulators |
| 06/02/2005 | WO2005028445A3 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain |
| 06/02/2005 | US20050119489 Antidiabetic, anorexigenic, hypotensive, and anticholesterol agents that are synergistically combined with other active agents; obesity, premenstrual tension, hyperlipidemia, myocardial infarction and skin disorders |
| 06/02/2005 | US20050119484 Mitotic kinesin inhibitors |
| 06/02/2005 | US20050119332 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) |
| 06/02/2005 | US20050119304 N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(1H-indazol-5-yl)urea; vanilloid receptor (VR1) antagonist; blockage of neurotransmitter release |
| 06/02/2005 | US20050119246 2-(4-{[1-(2,2-dimethylpropanoyl)-4-piperidinyl]methyl}-3,5-dimethyl-1H-pyrazol-1-yl)-1-methylethylcarbamate; appetite suppressants; obesity, diabetes, feeding behavior, bulimia, anorexia nervosa and premenstrual tension; side effect reduction |
| 06/02/2005 | US20050119182 Bioassay; detect compound as antigonist; antiserotonine agents |
| 06/02/2005 | US20050119129 Substituted aryl ketones |
| 06/02/2005 | DE10351088A1 Verfahren zum Herstellen von fluormethyl-substituierten Heterocyclen A method of producing fluoromethyl-substituted heterocycles |
| 06/02/2005 | DE10349500A1 Verfahren zum Herstellen von 2-Dihalogenacyl-3-amino-acrylsäureestern und 3-Dihalogenmethyl-pyrazol-4-carbonsäureestern Acrylic acid esters, 2-dihaloacyl-3-amino-process for producing and 3-dihalomethyl-pyrazole-4-carboxylic acid esters |
| 06/02/2005 | CA2545711A1 Urea derivatives as kinase modulators |
| 06/02/2005 | CA2545710A1 Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1) |
| 06/02/2005 | CA2545196A1 Pyrazolopyrimidines |
| 06/01/2005 | EP1535939A1 Blocked polyisocyanate |
| 06/01/2005 | EP1535909A2 Cyclic amine derivatives and their use as drugs |
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534685A1 1h-indazole-3-carboxamide compounds as cyclin dependent kinases (cdk) inhibitors |
| 06/01/2005 | EP1534684A1 Indazole-aminoacetonitrile derivatives having special pesticidal activity |
| 06/01/2005 | EP1534683A2 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 06/01/2005 | EP1534680A1 Prenylation inhibitors and methods of their synthesis and use |
| 06/01/2005 | EP1534671A2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 06/01/2005 | EP1534390A2 3'- (2z)- 1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy- 1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 06/01/2005 | EP1534282A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 06/01/2005 | EP1534279A2 Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use |
| 06/01/2005 | EP1534273A2 Modulators of the glucocorticoid receptor and method |
| 06/01/2005 | EP1351959B1 Novel pleuromutilin derivatives |
| 06/01/2005 | EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 06/01/2005 | EP1235811B1 Pyrazolecarboxamide and pyrazolethioamide as fungicide |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | EP0993441B1 INHIBITORS OF p38 |
| 06/01/2005 | EP0991625B1 Inhibitors of factor xa with a neutral p1 specificity group |
| 06/01/2005 | CN1622942A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 06/01/2005 | CN1204138C Pyrazolo [4, 3-d] pyrimidine derivs. |
| 06/01/2005 | CN1204123C N-phenyl pyrazole derivative pesticide |
| 06/01/2005 | CN1203852C Valdecoxib compositions |
| 05/31/2005 | US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis |
| 05/31/2005 | US6900232 For therapy of tumor metastasis, solid tumor growth (neoplasia), osteoporosis, Paget's disease, humoral hypercalcemia of malignancy, osteopenia, angiogenesis, including tumor angiogenesis and lymphangiogenesis |
| 05/26/2005 | WO2005047421A1 Organic element for electroluminescent devices |
| 05/26/2005 | WO2005047273A1 Thiazole and pyrazole derivatives as flt-3 kinase inhibitors |
| 05/26/2005 | WO2005046683A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/26/2005 | WO2005046680A1 Percutaneous absorption type cerebral protective agent |
| 05/26/2005 | WO2005046679A1 Immuno inhibitory pyrazolone compounds |
| 05/26/2005 | US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/26/2005 | US20050113576 especially isoquinolines 5-substituted with urea, carboxamide or carbamate groups, e.g., N-[2-(3-fluorophenyl)ethyl]-N'-isoquinolin-5-ylurea; useful for treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity |
| 05/26/2005 | US20050113550 Reaction product of polyisocyanate, pyrazole and diol; usec for crosslinked polyurethane coatings |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113442 Antiamyloid phenylsulfonamides: N-cycloalkylcarboxamides derivatives |
| 05/26/2005 | US20050113440 Compounds that modulate PPAR activity and methods for their preparation |
| 05/26/2005 | US20050113423 Modulators of ATP-binding cassette transporters |
| 05/26/2005 | US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 05/26/2005 | US20050113370 Therapeutic substituted indazole derivatives |
| 05/26/2005 | US20050113369 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 05/26/2005 | US20050112197 Celecoxib dissolving in polyethylene glycol; antiinflammatory agents, osteoporosis, respiratory system disorders, antitumor agents, analgesics |
| 05/26/2005 | CA2545350A1 Thiazole and pyrazole derivatives as flt-3 kinase inhibitors |
| 05/26/2005 | CA2541949A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/25/2005 | EP1533292A1 Dibenzylamine compound and medicinal use thereof |
| 05/25/2005 | EP1532152A1 Novel polymorph of n-methyl-n-(3- 3- 2-thienylcarbonyl]-pyrazol- 1,5-alpha]-pyrimidin-7-yl phenyl)acetamide and compositions and methods related thereto |
| 05/25/2005 | EP1532116A1 1h-pyrazol derivatives, method for producing the same and the use thereof as nitrification inhibitors |
| 05/25/2005 | EP1531822A1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 05/25/2005 | EP1531812A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis |
| 05/25/2005 | EP1531811A2 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 05/25/2005 | EP0880362B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist |
| 05/25/2005 | DE10352082A1 Hexylcarboxanilide Hexylcarboxanilides |
| 05/25/2005 | DE10352067A1 Isopentylcarboxanilide Isopentylcarboxanilide |
| 05/25/2005 | DE10349502A1 1,3-Dimethylbutylcarboxanilide 1,3-Dimethylbutylcarboxanilide |
| 05/25/2005 | DE10349497A1 N-substituierte Pyrazolylcarboxanilide N-substituted pyrazolylcarboxanilides |
| 05/25/2005 | DE10347383A1 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors |
| 05/25/2005 | CN1620449A Diamide invertebrate pest control agents |
| 05/25/2005 | CN1620436A Process for producing 3-unsubstituted 5-amino-4-nitrosopyrazole compound, and 2-hydroxyimino-3-oxopropionitrile, 3-hydrazono-2-hydroxyiminopropionitrile compound, and processes for producing these |
| 05/25/2005 | CN1620292A Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors |
| 05/25/2005 | CN1203047C Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 05/24/2005 | US6897322 Cyclizing a beta-ketoester with hydrazine and reacting the product with chlorodifluoromethane and an alkylating compound |
| 05/24/2005 | US6897240 Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use |
| 05/24/2005 | US6897232 Activate soluble guanylate cyclase; for use treating cardiovascular disorders, erectile dysfunction, diabetes, and cirrhosis of the liver, kidney disorders, and learning disability |
| 05/24/2005 | US6897231 Jun n- terminal kinase inhibitors such as 3-(4-methoxyphenyl)-1H-indazole |
| 05/19/2005 | WO2005044817A1 Modulators of cellular adhesion |
| 05/19/2005 | WO2005044806A1 Process for the preparation of a trifluoromethylthioether |
| 05/19/2005 | WO2005044804A1 Method for the production of fluoromethyl-substituted heterocycles |
| 05/19/2005 | WO2005044785A1 Aralkyl amines as cannabinoid receptor modulators |
| 05/19/2005 | WO2005044130A1 Pdk-1/akt signaling inhibitors |
| 05/19/2005 | WO2005030128A3 Pyrazole modulators of metabotropic glutamate receptors |
| 05/19/2005 | WO2005028429A3 Haloalkyl containing compounds as cysteine protease inhibitors |
| 05/19/2005 | US20050107616 Alpha-ketoamide derivatives as cathepsin k inhibitors |
| 05/19/2005 | US20050107457 Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| 05/19/2005 | US20050107456 such as N-(4-phenyl)-3-(4-chlorophenyl)-4-(4-cyanopyrazol-1-yl)-4,5-dihydro-1-pyrazolecarboxanilide, optionally mixed with extenders and/or surfactants, used for controlling pests |
| 05/19/2005 | US20050107383 such as 2-(2-propenylthio)-4-(4-trifluoromethylphenyl)benzonitrile; for farm and garden pests including mites, lepidopterans, hemipterans, hymenopterans, orthopterans and isopterans; antiviral agent, fungicide, herbicide |
| 05/19/2005 | US20050107368 Inhibitors of cathepsin S |
| 05/19/2005 | DE10347386A1 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors |